Chief Scientific Officer, H2Ocean; Dr. Anita Kinney (M), President, American Society of Preventive Oncology; Eddie Kolos (R), ...

Median progression free survival (PFS) was 6.9 months in patients treated with DATROWAY versus 4.9 months with chemotherapy. A confirmed objective response rate (ORR) of 36% was observed in the ...

Eddie Kolos, Founder & CEO of H2Ocean, with Dr. Rajiv Saini, Chief Scientific Officer, H2Ocean, at The University of Texas MD Anderson Cancer Cent ...

Then there is laser therapy, which uses focused light beams to target and destroy cancer cells. Brachytherapy is a form of radiation therapy. A patient doesn’t need any chemotherapy or targetted ...

With this assistance, we increased food donations, provided specialized hygiene items safe for chemotherapy patients, tools to help their comfort, and more,” shared Brauer, executive director. “This ...

On Tuesday, The Daily Telegraph reported 486 cancer patients had their chemotherapy appointments cancelled. Instead, the figures related to oncology appointments that had been cancelled ...

Patients traveled to other states frequently for surgical procedures (8.3%), radiation therapy (6.7%) or chemotherapy (5.6%). Cross-state travel varied based on cancer type. For example ...

Chemotherapy disrupts brain connectivity in breast cancer patients The decision-making part of the brain undergoes alterations The disruptions worsen as chemotherapy continues A new study in the ...

Elective surgeries were cancelled and cancer patient chemotherapy was canned and hospital beds closed as doctors walked out of hospitals in a bitter wage dispute with the NSW government.

In TROPION-Breast01, DATROWAY significantly reduced the risk of disease progression or death by 37% compared to investigator’s choice of chemotherapy (hazard ratio [HR]=0.63; 95% confidence interval ...